Becton Dickinson (XSWX:BDX) FFO per Share


XSWX:BDX Becton Dickinson & Co XSWX:BDX
77 GF Score
Price CHF125.66
GF Value CHF151.22
! 3 Warning Signs
View Full Analysis

What is Becton Dickinson FFO per Share?

FFO per Share only applies to REITs.

XSWX:BDX
77GF Score
Becton Dickinson & Co XSWX:BDX
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Becton Dickinson (XSWX:BDX) Overvalued in 2026?

Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued. The current stock price of CHF125.66 is trading 16.9% below its estimated GF Value™ of CHF151.22.

Key valuation signals for XSWX:BDX:

  • FFO per Share:
  • GF Value™: CHF151.22 vs. price of CHF125.66 (16.9% below fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the XSWX:BDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Becton Dickinson Business Description

Address 1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
77GF Score

Get the complete analysis for XSWX:BDX

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF125.66
Price
CHF151.22
GF Value